Sitemap
June 13, 2017 Articles
Filter by Available Specialty
- Advanced HIV disease at ART initiation declines in low-, middle-income countries
- AMA adopts policies to protect the health of immigrants, refugees
- AMA supports efforts to combat ‘dangerous’ synthetic, injectable drugs
- AMA, AHA, ADA, others join forces to protect patient access to health care
- Autoantigen GAD vaccine fails to delay, prevent type 1 diabetes in high-risk children
- Cross-linking decreased maximum keratometry value at 1 year
- Cumulative incidence of renal failure increases with longer type 1 diabetes duration
- Deep perioperative infection risk after THA was greater with higher HbA1c levels
- Deferred stenting fails to reduce infarct size in STEMI
- Durasert for posterior segment uveitis meets primary efficacy endpoint in phase 3 trial
- Early surgery improves outcomes in acute ulcerative colitis
- Educational attainment inversely associated with lifetime CVD risk
- Endovascular repair of postdissecting aneurysms safe for high-risk surgical patients
- FDA boxed warning reduces erythropoietin-stimulating agent use
- FDA clears rapid diagnostic test for E. histolytica
- FDA grants fast track designation for tanezumab in treatment of chronic pain
- FDA grants Fast Track Designation to SAGE-217 for MDD
- FDA grants orphan drug designation to tucatinib for brain metastases
- Ferrous sulfate effective for pediatric iron-deficiency anemia
- Foamix begins dosing in phase 3 trials of minocycline foam for rosacea
- German hand hygiene campaign nearly doubles hand rub use in hospitals
- Global burden of diabetes complications ‘substantial,’ continues to grow
- Good response rare for antipsychotics in acute schizophrenia
- Hypofractionated radiotherapy effective for localized prostate cancer
- Increased intake of fruits, vegetables may lower risk for PAD
- Infant nutrition, maternal obesity affect risk for NAFLD in adolescents
- Inotek reports $10.7 million first-quarter net loss
- Intensive BP lowering may reduce risk for LV hypertrophy
- Momelotinib noninferior to ruxolitinib for spleen response in myelofibrosis
- Nearly 1 in 3 people worldwide overweight or obese
- Neuropsychological measures useful for detecting preclinical Alzheimer's disease
- New drug shows promise in patients with narcolepsy, sleep apnea
- Objective functional impairment baseline severity stratification seen as valid for degenerative disc disease
- Oncologist chosen as American Medical Association’s president-elect
- Patients with OCD lesions, UCL injuries had greater varus, valgus angles vs patients with uninjured elbows
- PCP-based skin cancer screening feasible
- Pediatricians crucial to prevent firearm-related injuries in children
- Regulus plans to discontinue micro-RNA candidate for HCV
- Risk for major adverse CV events modest with prediabetes
- Sientra to acquire Miramar Labs, miraDry
- Signet launches blue light-blocking lenses
- Survey shows dry eye symptoms hamper office work
- Teen interest in tobacco ads linked to increased risk of future smoking
- Tight glycemic control plus overmedication may increase hospitalizations
- Top five stories about osteoarthritis
- Use patient-centered approaches to discuss cancer screening cessation
- VIDEO: New device can measure tissue glucose at the earlobe
- VIDEO: Some patients with diabetes at high risk for edema after cataract surgery
- Warren Alpert Foundation recognizes leaders in cancer immunology
- WHO: Bhutan, Maldives eliminate measles 3 years ahead of schedule
- Zerbaxa active against P. aeruginosa in vitro